Metropolis Healthcare Ltd.
BSE: 542650 | Sector: Health care |
NSE: METROPOLIS | ISIN Code: INE112L01020 |
BSE 00:00 | 05 Mar | 1927.95 |
-35.25 (-1.80%) |
OPEN
1975.00 |
HIGH
1975.00 |
LOW
1916.15 |
NSE 00:00 | 05 Mar | 1928.60 |
-33.40 (-1.70%) |
OPEN
1970.00 |
HIGH
1970.00 |
LOW
1916.00 |
OPEN | 1975.00 |
PREVIOUS CLOSE | 1963.20 |
VOLUME | 3769 |
52-Week high | 2321.00 |
52-Week low | 993.20 |
P/E | 68.68 |
Mkt Cap.(Rs cr) | 9,852 |
Buy Price | 1929.75 |
Buy Qty | 45.00 |
Sell Price | 1955.00 |
Sell Qty | 5.00 |
About Metropolis Healthcare Ltd.
Dr. Sushil Kanubhai Shah one of the Promoters commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital having Dr. Kanubhai M. Shah Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30 1981 onwards. In June 1989...> More
Metropolis Healthcare Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
9,852 | |
EPS - TTM | (![]() |
[*S] | 28.07 |
P/E Ratio | (X) | [*S] | 68.68 |
Face Value | (![]() |
2 | |
Latest Dividend | (%) | 400.00 | |
Latest Dividend Date | 17 Feb 2021 | ||
Dividend Yield | (%) | 0.41 | |
Book Value / Share | (![]() |
[*S] | 115.53 |
P/B Ratio | (![]() |
[*S] | 16.69 |
News
-
Metropolis Healthcare to acquire Chennai-based diagnostic lab for Rs 511 cr
-
Stocks to watch: HDFC Bank, Metropolis Healthcare, Wipro, Airtel, DHFL
-
MARKETS: Indices end at record closing peaks; Nifty settles above 13,000
-
Dr Lal PathLabs, Metropolis: Here's how healthcare stocks look on charts
-
Thyrocare, Dr Lal PathLabs: Healthcare stocks can rally more, charts show
Announcement
-
Metropolis Healthcare Limited - Disclosure under SEBI Takeover Regulations
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
-
Metropolis Healthcare Limited - Analysts/Institutional Investor Meet/Con. Call Updates
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Metropolis Healthcare Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 274.78 | 222.85 | 23.3 |
Other Income | 3.74 | 2.19 | 70.78 |
Total Income | 278.52 | 225.04 | 23.76 |
Total Expenses | 188.13 | 159.29 | 18.11 |
Operating Profit | 90.39 | 65.75 | 37.48 |
Net Profit | 58.64 | 42.01 | 39.59 |
Equity Capital | 10.22 | 10.04 | - |
Metropolis Healthcare Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Laurus Labs | 351.30 | -4.63 | 18850.76 |
Max Healthcare | 199.05 | 1.95 | 18004.67 |
Fortis Health. | 177.60 | -0.48 | 13408.09 |
Metropolis Healt | 1927.95 | -1.80 | 9851.82 |
Narayana Hrudaya | 420.45 | -2.48 | 8592.32 |
Aster DM Health. | 142.85 | 0.39 | 7135.50 |
Poly Medicure | 712.95 | -0.29 | 6835.76 |
Metropolis Healthcare Ltd - SHAREHOLDING PATTERN
|
|
Metropolis Healthcare Ltd - Research Reports
Date | Broker | Action | Price | Report |
18/01/2021 | Edelweiss Research | Buy | 2183 | ![]() |
Metropolis Healthcare Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -1.53% | -1.57% | 2.66% | 2.81% |
1 Month | -11.06% | -10.96% | -0.64% | 0.09% |
3 Month | -3.38% | -3.33% | 11.81% | 12.67% |
6 Month | 7.89% | 7.99% | 31.41% | 31.80% |
1 Year | 6.57% | 6.56% | 31.02% | 32.56% |
3 Year | NA | NA | 49.36% | 44.21% |
Metropolis Healthcare Ltd - STOCK STRENGTH
Today's Low/High | 1916.15 | 1975.00 | |
Week Low/High | 1892.25 | 1999.00 | |
Month Low/High | 1892.25 | 2297.00 | |
YEAR Low/High | 993.20 | 2321.00 | |
All TIME Low/High | 904.85 | 2321.00 |
Quick Links for Metropolis Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices